Any allogeneic stem cell transplant recipient = 14 years of age and = 60 years of age
Bilirubin/ SGOT/SGPT < 5 × upper normal limits.
Creatinine < 2 × upper normal limits.
Ejection fraction = 50%, no severe arrhythmia.
Estimated life expectancy = 6 months.
Patients' CMV-DNA = 1000cp/ml in treatment group and being negative in prophylactic group.

NCT03004261_inc_T1
Procedure
allogeneic stem cell transplant
NCT03004261_inc_T2
Value
= 14 years
NCT03004261_inc_T3
Person
age
NCT03004261_inc_T4
Value
= 60 years
NCT03004261_inc_T5
Person
age
NCT03004261_inc_T6
Measurement
Bilirubin
NCT03004261_inc_T7
Measurement
SGOT
NCT03004261_inc_T8
Measurement
SGPT
NCT03004261_inc_T9
Value
< 5 × upper normal limits
NCT03004261_inc_T10
Measurement
Creatinine
NCT03004261_inc_T11
Value
< 2 × upper normal limits
NCT03004261_inc_T12
Measurement
Ejection fraction
NCT03004261_inc_T13
Value
= 50%
NCT03004261_inc_T14
Negation
no
NCT03004261_inc_T15
Qualifier
severe
NCT03004261_inc_T16
Condition
arrhythmia
NCT03004261_inc_T17
Observation
Estimated life expectancy
NCT03004261_inc_T18
Value
= 6 months
NCT03004261_inc_T19
Measurement
CMV-DNA
NCT03004261_inc_T20
Value
= 1000cp/ml
NCT03004261_inc_T21
Person
treatment group
NCT03004261_inc_T22
Person
prophylactic group
NCT03004261_inc_T23
Value
negative
NCT03004261_inc_T24
Scope
= 1000cp/ml in treatment group and being negative in prophylactic group